Pacific Biosciences Of California reported $-83379000 in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Accelerate Diagnostics AXDX:US USD -14961000 3.03M
Agilent A:US USD 438M 59M
Bruker BRKR:US USD 135.7M 2.8M
Danaher DHR:US USD 2.3B 281M
Fluidigm FLDM:US USD -21112000 7.92M
General Electric GE:US USD 787M 689M
Illumina ILMN:US USD -106000000 352M
Myriad Genetics MYGN:US USD -46000000 1000K
Nanostring Technologies NSTG:US USD -42681000 7.74M
Perkinelmer PKI:US USD 179.41M 57.36M
Quidel QDEL:US USD 112.9M 29.7M
Roche Holding ROG:VX 8.49B 3.05B
Thermo Fisher Scientific TMO:US USD 1.92B 156M
Waters WAT:US USD 287.53M 95.52M